-
Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis
26 Apr 2024 09:14 GMT
… is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, … shareholder, says the biotech faces “no real … its hepatitis C treatment, Incivek. After becoming the fastest drug ever … building better and better medicine.”
However, Vertex has …
-
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer
26 Feb 2024 13:30 GMT
… and commercialization of novel treatments for patients suffering from serious … for the company’s hepatitis C and cystic fibrosis … the U.S. launches of Incivek® (telaprevir) and Orkambi® ( … member of Zynerba Pharmaceuticals, a public biotech company focused on …
-
Wren Taps Vertex Veteran Executives and Other Leaders to Advance First-in-Class Small-Molecule Drugs into Clinical Testing for Neurodegenerative Diseases
08 Dec 2022 22:21 GMT
… 's seven FDA-approved drugs.
In addition to … three first-in-class medicines—INCIVEK® for hepatitis C, and KALYDECO® … medicines to be tested in humans, currently in Phase 3 clinical trials … , Head of Drug Discovery at Rectify Pharmaceuticals and served as …
-
Now a biopharma powerhouse, Vertex’s R&D bedrock could deliver tomorrow’s blockbusters
30 Apr 2024 15:59 GMT
… chief scientific officer, Vertex Pharmaceuticals
Permission granted by Vertex … its relatively new hepatitis C drug Incivek began facing a … jeopardy as new treatments threatened to “out … -drug combinations, including the medications Orkambi and Symdeko, won FDA …
-
The CEO of one of 2022's top biotechs told us how her unusual strategy helped Vertex dodge the industry's downturn
21 Sep 2022 13:56 GMT
… one seemed to tell Vertex Pharmaceuticals about biotech';s recession.
… in 2011, when its hepatitis C drug Incivek won approval and soon rocketed … the one-time treatment have gone from suffering crippling … out a pain medicine that would be pretty easy.…
-
Mavyret for hepatitis C
27 Jul 2022 00:15 GMT
… t reported in clinical trials.
† Mavyret has … hepatitis C medications. Specifically, they must have received treatment … , such as telaprevir (Incivek) or boceprevir (Victrelis) … Drug Administration (FDA). A boxed warning alerts doctors and patients about drug …
-
Drug Interactions With Interstitial Lung Disease Pharmacotherapy
15 Jul 2022 16:02 GMT
… Treatment Guidelines Treatment … drugs, phenothiazines, sulfonamides, sulfonylureas, thiazide diuretics, tetracyclines, and tricyclic antidepressants … nonprescription medications … Incivek (telaprevir) package insert. Cambridge, MA: Vertex Pharmaceuticals …
-
Hepatitis Drugs Market Analysis with Impact of COVID-19, Top Companies, Trends, Size, Growth, Share, Demand, Future Opportunity Outlook 2025
19 Oct 2021 04:36 GMT
… Pharmaceuticals
● Abbvie
● Achillion Pharmaceuticals
● Bristol-Myers Squibb
Market Overview: The global Hepatitis Drugs … ● VEMLIDY ● EPCLUSA ● SOVALDI ● INCIVEK ● OLYSIO/VICTRELIS/VIREAD … orders. Except for the medical supplies and life support …
-
Artelo Biosciences Announces Appointment of Senior Pharmaceutical Executive Gregory R. Reyes, M.D., Ph.D., to Board of Directors
02 Dec 2020 13:30 GMT
… years of experience in biotech and large pharma to … small molecule antiviral treatments for chronic hepatitis C and which … with Vertex’s Incivek™ as the ‘best pharmaceutical agent’ in … Hopkins School of Medicine. He completed his medical and postdoctoral …
-
Vertex: Incivek for hepatitis C patients approved by FDA
17 Sep 2020 00:57 GMT
… vaccination remains undiscovered. More recently Vertex Pharmaceuticals proclaimed that the U.S. FDA … genotype 1 chronic hepatitis C that causes … who were given Incivek combination treatment essentially developed … 7 hotline number. Doctors would be offered …